Decaestecker K - Search Results

1

Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.

Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, De Maeseneer D, Reynders D, Goetghebeur E, Van Dorpe J, Verbeke S, Annala M, Brochez L, Van der Eecken K, Wyatt AW, Rottey S, Ost P. Sundahl N, et al. Among authors: decaestecker k. Eur Urol. 2019 May;75(5):707-711. doi: 10.1016/j.eururo.2019.01.009. Epub 2019 Jan 19. Eur Urol. 2019. PMID: 30665814 Clinical Trial.

2

Privacy-proof Live Surgery Streaming: Development and Validation of a Low-cost, Real-time Robotic Surgery Anonymization Algorithm.

De Backer P, Simoens J, Mestdagh K, Hofman J, Eckhoff JA, Jobczyk M, Van Eetvelde E, D'Hondt M, Moschovas MC, Patel V, Van Praet C, Fuchs HF, Debbaut C, Decaestecker K, Mottrie A. De Backer P, et al. Among authors: decaestecker k. Ann Surg. 2024 Jul 1;280(1):13-20. doi: 10.1097/SLA.0000000000006245. Epub 2024 Feb 23. Ann Surg. 2024. PMID: 38390732 Free PMC article.

3

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.

Berkovic P, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, Decaestecker K, Villeirs G, Vuye P, Ost P. Berkovic P, et al. Among authors: decaestecker k. Clin Genitourin Cancer. 2013 Mar;11(1):27-32. doi: 10.1016/j.clgc.2012.08.003. Epub 2012 Sep 24. Clin Genitourin Cancer. 2013. PMID: 23010414

4

Safe introduction of robot-assisted radical prostatectomy after a training program in a high-volume robotic centre.

Lumen N, Van Praet C, De Troyer B, Fonteyne V, Oosterlinck W, Decaestecker K, Mottrie A. Lumen N, et al. Among authors: decaestecker k. Urol Int. 2013;91(2):145-52. doi: 10.1159/000350652. Epub 2013 Jul 11. Urol Int. 2013. PMID: 23860435

5

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.

Van Praet C, Ost P, Lumen N, De Meerleer G, Vandecasteele K, Villeirs G, Decaestecker K, Fonteyne V. Van Praet C, et al. Among authors: decaestecker k. Radiother Oncol. 2013 Nov;109(2):222-8. doi: 10.1016/j.radonc.2013.08.021. Epub 2013 Sep 7. Radiother Oncol. 2013. PMID: 24016674

6

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome.

Fonteyne V, Lumen N, Ost P, Van Praet C, Vandecasteele K, De Gersem Ir W, Villeirs G, De Neve W, Decaestecker K, De Meerleer G. Fonteyne V, et al. Among authors: decaestecker k. Radiother Oncol. 2013 Nov;109(2):229-34. doi: 10.1016/j.radonc.2013.08.006. Epub 2013 Sep 7. Radiother Oncol. 2013. PMID: 24016677

7

Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?

Van Praet C, Libbrecht L, D'Hondt F, Decaestecker K, Fonteyne V, Verschuere S, Rottey S, Praet M, De Visschere P, Lumen N; Uro-Oncology Group Ghent. Van Praet C, et al. Among authors: decaestecker k. Clin Genitourin Cancer. 2014 Jun;12(3):160-6. doi: 10.1016/j.clgc.2013.11.008. Epub 2013 Nov 12. Clin Genitourin Cancer. 2014. PMID: 24361055

8

Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.

Ost P, Decaestecker K, Lambert B, Fonteyne V, Delrue L, Lumen N, Ameye F, De Meerleer G. Ost P, et al. Among authors: decaestecker k. Prostate. 2014 Feb;74(3):297-305. doi: 10.1002/pros.22750. Prostate. 2014. PMID: 24395565

9

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence.

Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T, De Vos F, Huysse W, Hautekiet A, Maes G, Ost P. Decaestecker K, et al. Radiat Oncol. 2014 Jun 12;9:135. doi: 10.1186/1748-717X-9-135. Radiat Oncol. 2014. PMID: 24920079 Free PMC article.

10

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications.

Van Praet C, Decaestecker K, Fonteyne V, Ost P, De Visschere P, Verschuere S, Rottey S, Lumen N. Van Praet C, et al. Among authors: decaestecker k. Int J Urol. 2014 Nov;21(11):1138-43. doi: 10.1111/iju.12534. Epub 2014 Jun 25. Int J Urol. 2014. PMID: 24964296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters